SurModics News

SurModics (SRDX) Was Downgraded to a Hold Rating at Barrington

TipRanksMay 30 09:15 ET

Surmodics Analyst Ratings

BenzingaMay 29 10:24 ET

SurModics (SRDX) Was Downgraded to a Hold Rating at Needham

TipRanksMay 29 10:15 ET

SurModics (SRDX) Gets a Buy From Lake Street

TipRanksMay 29 09:05 ET

Analysts Are Bullish on These Healthcare Stocks: Assertio Therapeutics (ASRT), SurModics (SRDX)

TipRanksMay 29 09:00 ET

Surmodics Analyst Ratings

BenzingaMay 2 14:24 ET

Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and SurModics (SRDX)

TipRanksMay 2 09:20 ET

Surmodics Analyst Ratings

BenzingaMay 1 14:27 ET

SurModics Outperforms With Raised Guidance and Strong Product Momentum: Buy Rating Reaffirmed

TipRanksMay 1 14:06 ET

Analysts Offer Insights on Healthcare Companies: SurModics (SRDX) and Pfizer (PFE)

TipRanksMay 1 09:05 ET

Analysts Offer Insights on Healthcare Companies: Genprex (GNPX) and SurModics (SRDX)

TipRanksApr 10 10:50 ET

Surmodics Analyst Ratings

BenzingaApr 10 10:47 ET

Barrington Trims Price Target on SurModics to $70 From $71, Keeps Outperform Rating

MT NewswiresFeb 6 10:10 ET

Analysts Are Bullish on Top Healthcare Stocks: SurModics (SRDX), Biogen (BIIB)

TipRanksFeb 6 09:20 ET

SurModics Surpasses Estimates: A Buy Rating Reaffirmed With Increased Price Target

TipRanksFeb 1 11:35 ET

Analysts Offer Insights on Healthcare Companies: SurModics (SRDX), Urogen Pharma (URGN) and Blueprint Medicines (BPMC)

TipRanksJan 22 14:40 ET

Surmodics Analyst Ratings

BenzingaNov 9, 2023 11:40 ET

Barrington Ups Price Target on SurModics to $71 From $69 After Better-than-Expected Q4/23 Results, Keeps Outperform Rating

MT NewswiresNov 9, 2023 10:41 ET

SurModics Outperforms Projections: Encouraging Financial Results and Promising Product Portfolio Prompt Buy Rating and Raised Price Target

TipRanksNov 9, 2023 10:05 ET

Needham Maintains Buy on Surmodics, Lowers Price Target to $44

BenzingaNov 8, 2023 17:10 ET